ANI Pharmaceuticals begins trial of gel to treat gout at Massachusetts General Hospital.

ANI Pharmaceuticals has launched a Phase 4 clinical trial at Massachusetts General Hospital to test two dose levels of Purified Cortrophin Gel for treating acute gout flares. The study, led by Dr. Hyon Choi, aims to provide more data on the gel's effectiveness and safety, focusing on pain reduction and other outcomes in up to 160 patients over a week. This research could help doctors better manage gout, a painful condition affecting millions.